A clinical pharmacological study of K-115 ophthalmic solutio
Phase 2
- Conditions
- POAG or OH patients
- Registration Number
- JPRN-jRCT2080220683
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
1.POAG or OH patients
2.Intraocular pressure(IOP) >= 21mmHg in one eye and < 30mmHg in both eyes
Exclusion Criteria
1.Patients thought to use ophthalmic solution or ophthalmic ointment other than K-115 ophthalmic solution
2.Patients not able to stop glaucoma medication other than K-115 ophthalmic solution
3.Patients underwent ophthalmological surgery or laser surgery in the past
4.Patients not able to stop using contact lenses
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, safety
- Secondary Outcome Measures
Name Time Method